CHRNA4 and nicotine dependence: Once such compounds of interest are identified, they could be studied in detail using lower-throughput assays that could focus, for example, on how they (singly, or in combination) modify the action of nicotine at the levels of nAChR subtype function and/or animal models of behaviors related to nicotine/tobacco use disorder.